Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
oleiferoside C
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
Oleiferoside C is a natural triterpenoid saponin of the oleanane type, isolated from the ethanol extract of the roots of *Camellia oleifera*. Structurally, it is characterized by an oleanane-type aglycone with sugar moieties attached to the C-3 position. Research has demonstrated that oleiferoside C possesses potent in vitro cytotoxic activity against various human tumor cell lines, including lung cancer (A549), melanoma (B16), hepatocellular carcinoma (BEL-7402), and breast cancer (MCF-7), with reported IC50 values below 10 µM. It is being investigated for its potential as a lead compound in oncology for the treatment of various solid tumors.
Beyond the preview
Go deeper on oleiferoside C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on oleiferoside C.